Posted by Michael Wonder on 01 Apr 2022
Thousands of people set to benefit from first new treatment for osteoporosis for over a decade
1 April 2022 - Thousands of people in England and Wales with severe osteoporosis who are at high risk of fracture are set to benefit from a new treatment – romosozumab – after NICE recommended it for people after menopause in final draft guidance published today by NICE.
Over 20,000 people could be eligible for the treatment according to the company. Clinical trial evidence showed that romosozumab (Evenity; UCB) followed by alendronic acid is more effective at reducing the risk of fractures than alendronic acid alone.
